I Boumaza, S Srinivasan, WT Witt, C Feghali- … - Journal of Autoimmunity, 2009 - Elsevier Cell-based therapies offer considerable promise for prevention or cure of diabetes. We explored
the potential of autologous, self-renewing, mesenchymal stem cells (MSC) as a clinically-applicable
approach to promote glucose homeostasis. In vitro-expanded syngeneic bone marrow- ... Cited by 7 - Related articles - All 2 versions
MG Solari, S Srinivasan, I Boumaza, J Unadkat, G … - Journal of Autoimmunity, 2009 - Elsevier Allogeneic islet transplantation is an option to treat diabetes however there are obstacles that
are limiting its clinical use. We have examined whether mesenchymal stem cells (MSC) improve
islet graft survival and whether such therapy allows for better graft acceptance with ... Cited by 5 - Related articles - All 2 versions
- ►nbdymnwk.com [PDF] A Salonia - european urology, 2009 - Elsevier Step by step, researchers have learned (1) that ED is clearly a more frequent complaint in patients
with concomitant CVD and medical comorbidities such as hypertension,
hypercholesterolemia, coronary artery disease (CAD), and diabetes mellitus (DM) [1]; (2) ... Cited by 1 - Related articles - All 46 versions
JD Jin, HX Wang, FJ Xiao, JS Wang, X Lou, LD Hu, … - … and Biophysical Research …, 2008 - Elsevier The debris from human bone marrow (BM) samples is generally filtered out and discarded prior
to isolation of mesenchymal stem cells (MSCs). The purpose of this study is to develop a method
to harvest MSCs from the debris and investigate their biological characteristics compared ... Cited by 1 - Related articles - All 3 versions
N Datz, M Rachmiel - Pediatric diabetes, 2009 - ccmjournal.org In his opening remarks, conference president Dr Kuben Pillay defined the magnitude of the problem
of diabetes in the world today: currently, there are 440 000 children aged 0-14 yr with type 1
diabetes mellitus (T1DM) all over the world with a 3% annual increase and estimated ... Cited by 1 - Related articles - All 6 versions
Y Zhao, B Lin, R Darflinger, Y Zhang, MJ Holterman, … - PLoS ONE, 2009 - pubmedcentral.nih.gov Here, we report that treatment of established autoimmune-caused diabetes in NOD mice with
purified autologous CD4 + CD62L + Tregs co-cultured with human cord blood stem cells
(CB-SC) can eliminate hyperglycemia, promote islet β-cell regeneration to increase β-cell ... Cited by 2 - Related articles - All 4 versions
AM Madec, R Mallone, G Afonso, E Abou Mrad, A … - Diabetologia, 2009 - Springer Abstract Aims/hypothesis Displaying immunomodulatory capacities, mesenchymal stem cells
(MSCs) are considered as benefi- cial agents for autoimmune diseases. The aim of this study
was to examine the ability of MSCs to prevent autoimmune diabetes in the NOD mouse ... Cited by 1 - Related articles - All 2 versions
L Mazzini, A Vercelli, I Ferrero, K Mareschi, M … - Expert Opin. Biol. … - informahealthcare.com Amyotrophic lateral sclerosis (ALS) is a devastating incurable neurodegenerative disease that
targets motor neurons, manifesting as a linear decline in muscular function and leading to death
within 2 – 5 years of diagnosis. The vast majority of ALS cases are sporadic, the ... Cited by 1 - Related articles - All 5 versions
H Abdelkrim, DB Juan, W Jane, A … - Journal of Cellular …, 2009 - interscience.wiley.com Stem cells have fascinated the scientific and clinical communities for over a century. Despite
the controversy that surrounds this field, it is clear that stem cells have the potential to revolutionise
medicine. However, a number of significant hurdles still stand in the way of the realization ... Related articles - All 2 versions
É Mezey, B Mayer, K Németh - Oral Diseases, 2009 - interscience.wiley.com Adult and embryonic stem cells have drawn a lot of attention in the last decade as new tools
in regenerative medicine. A variety of such cells have been discovered and put forward as candidates
for use in cell replacement therapy. Investigators hope that some, if not all, of our organs ... Related articles - All 2 versions
